Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

M A Sovak; R E Bellas; D W Kim; G J Zanieski; A E Rogers; A M Traish; G E Sonenshein

doi:10.1172/JCI119848

Published December 15, 1997 - More info

View PDF

Abstract

Expression of nuclear factor-kappaB (NF-kappaB)/Rel transcription factors has recently been found to promote cell survival, inhibiting the induction of apoptosis. In most cells other than B lymphocytes, NF-kappaB/Rel is inactive, sequestered in the cytoplasm. For example, nuclear extracts from two human untransformed breast epithelial cell lines expressed only very low levels of NF-kappaB. Unexpectedly, nuclear extracts from two human breast tumor cell lines displayed significant levels of NF-kappaB/Rel. Direct inhibition of this NF-kappaB/ Rel activity in breast cancer cells induced apoptosis. High levels of NF-kappaB/Rel binding were also observed in carcinogen-induced primary rat mammary tumors, whereas only expectedly low levels were seen in normal rat mammary glands. Furthermore, multiple human breast cancer specimens contained significant levels of nuclear NF-kappaB/Rel subunits. Thus, aberrant nuclear expression of NF-kappaB/Rel is associated with breast cancer. Given the role of NF-kappaB/Rel factors in cell survival, this aberrant activity may play a role in tumor progression, and represents a possible therapeutic target in the treatment of these tumors.

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

M A Sovak, R E Bellas, D W Kim, G J Zanieski, A E Rogers, A M Traish, and G E Sonenshein

Article tools

Metrics

Go to

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

M A Sovak, R E Bellas, D W Kim, G J Zanieski, A E Rogers, A M Traish, and G E Sonenshein

Article tools

Metrics

Go to

Sign up for email alerts